Distinguishing Tardive Dyskinesia From Other Drug-Induced Movement Disorders

Source: Movement Disorders+ Summit 2022
Download Slideset
The presentation will focus on tardive dyskinesia, clinical pearls to distinguish it from other drug-induced movement disorders, and how assessment of the impact of tardive dyskinesia can aid treatment decisions with first-line VMAT2 inhibitor therapy.
Stuart Isaacson, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 854 KB
Released: September 27, 2022

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Teva Pharmaceuticals

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings